Open AccessAnalysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence
Author(s) -
Shuai Hao,
Wuguo Tian,
Jing Zhao,
Yi Chen,
Xiaohua Zhang,
Bo Gao,
Yonghong He,
Dong-Hua Luo
Publication year - 2020
Publication title -
journal of breast cancer/journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 36
eISSN - 2092-9900
pISSN - 1738-6756
DOI - 10.4048/jbc.2020.23.e41
Subject(s) - medicine , breast cancer , oncology , cancer , circulating tumor dna
Real-time detection and intervention can be used as potential measures to markedly decrease breast cancer mortality. Assessment of circulating tumor DNA (ctDNA) may offer great benefits for the management of breast cancer over time. However, the use of ctDNA to predict the effectiveness of neoadjuvant treatment and recurrence of breast cancer has rarely been studied.